The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Furosemide 250mg in 25ml Solution for Injection/Infusion

Mercury Pharmaceuticals (Ireland) LtdPA0073/059/006

Main Information

Trade NameFurosemide 250mg in 25ml Solution for Injection/Infusion
Active SubstancesFurosemide
Dosage FormSolution for injection/infusion
Licence HolderMercury Pharmaceuticals (Ireland) Ltd
Licence NumberPA0073/059/006

Group Information

ATC CodeC03CA Sulfonamides, plain
C03CA01 furosemide


License statusAuthorised
Licence Issued28/05/1990
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back